Ira Duarte serves as the Chief Financial Officer at Heron Therapeutics Inc., a position that underscores her significant expertise in financial management and strategic planning within the biopharmaceutical industry. With a robust background in finance, Duarte has held various senior financial roles that have equipped her with the skills necessary to navigate the complex financial landscapes of publicly traded companies. Prior to joining Heron Therapeutics, she was the CFO at another prominent biopharmaceutical firm, where she successfully led the company through multiple financing rounds and helped to secure partnerships that were crucial to the company's growth and development. At Heron Therapeutics, Duarte's role involves overseeing the company's financial operations, which includes managing budgets, financial planning, and reporting. Her strategic vision has been instrumental in guiding the company towards sustainable growth and profitability. Under her leadership, Heron Therapeutics has seen improvements in its financial health, including more efficient capital allocation and enhanced investor relations. Duarte's ability to communicate complex financial information clearly and effectively has also played a key role in strengthening the company's position in the market. In addition to her professional achievements, Duarte is recognized for her commitment to mentoring young professionals in the finance sector. She actively participates in industry conferences and panels, sharing her insights and experiences to help cultivate the next generation of financial leaders. Her contributions to Heron Therapeutics and the broader industry highlight her as a pivotal figure in the biopharmaceutical sector, dedicated to driving innovation and financial excellence.